Member Info for flushfrank

*should
It’s number 6 for me

Once we get H1 results/update we so see a long overdue re-rate. Question is far can we see this go?
1. £200m - £2.83
2. £250m - £3.54
3. £300m - £4.25
4. £350m - £4.96
5. £400m - £5.66
6. £500m - £7.08
7. £600m - £8.50
8. £750m - £10.62
9. £1.0b - £14.16
10. £1.5b - £21.24

Agree, really are still in their infancy. Expected more this far in.
Sold out my small holding here & added to NCYT. Are miles ahead in comparison.

He keeps referring to confidentiality. However using the following of the share to promote his own company (can’t blame him, why not).
Has got me thinking, could this be a professional investors presentation, making clearer the complexed science behind the tests & Exsig products? Are we having boardroom meetings where a professional shoot would match with the professional team & superior product?
Just a thought ...

It’s looking like we’re not getting a June sales update. Was never promised & with all the press on the shortage of tests, I am super confident sales are just fine.
I’m presuming GM is saving all the goodies for one mega half year interim. Probably a good call as carries more weight than random updates.
IMHO with how this virus is again raging across the world, I can see this company going to £7 a share (£500m MCAP) this year.
Hope I’m proved right, as in big. Seeing this lull as the calm before the storm
GLA

8 of them in past 30 mins suppressing the SP.

Imo he/she will shortly regret selling so low, but each to their own.

£3 finish would be nice

Gave up counting but about 70 after hours trade in France at €3.20 gone through

Buy /sale it’s gone through now so can move on

Agree was a sell at that price vs size. Is maybe why we didn’t hit £3.

Bright side is it’s out the way & SP still at £2.87. Bodes well for Monday

GLA

Be an interesting last 15 imo. £2.95 close I’m going for

Agreed.

Least seeing some chunky buys going through at 280 now. Seems to have awoken

0.5b or 1b ...all debatable...what isn’t is ....I cannot believe this is still sub £3 / 200m MCAP

AVCT- yet to have a test - valued £296m
ODX - (Antibody) - might be able to sell to India soon - valued £67m
NCYT- 100% accurate WHO approved test - activity selling to 130 countries - valued £185m

Already reported contracted £120m of sales. This month to add. Plus zero debt, millions in the bank & new supporting products (Exsig) being sold to adding more £.
I am sure the market will re-rate this share very soon. Still £6 a share target for me, then review my position

Where do these shares keep coming from? Price dropped with constant 10k sells. Shorter ?

MCAP will be at the same level of £ sales shortly.

Come to those who wait.....
So I keep telling myself. I think it’s testing the patience of us all. Just 206 trades today. Was 10x not long ago.
Still holding for gold, I can wait. Although NCYT is def out of flavour at the moment. Envisage SP moving up end of month for July sales figures. Is the critical one really, to see if previous results were a one off lucky boom or this is a sustainable cash cow.
Would love GM to post another £50m.
Target remains SP £6 (£400m)
GLA

Just read back over the threads & he did indeed. Thinking the same. :)

90/10 split is it really. Wow.

Didn’t realise the impact of not getting the French secured. I was like...okay down to just 129 countries

Remember a while back was a crew doing a piece on Nova. Recall Spanish language being mentioned.

Never seen anything materialise ? Wonder if it’s Exsig promo ? Now out will be released?

Agreed, market doesn't know what to make of the new products. Its all about the numbers, which no one can at this moment in time predict (other than more sales). Not sure if Exsig sales will be reported separately to the test ? We'll have to wait & see.

I'm just glad of no delays (was a tad worried that was linked with the SP fall). GM & team again has delivered, on time, 3 products instead of 2 (bonus). Even better than just landing them, have them ready for immediate sale & scale plans in place to meet demand.
Solid professional company. Truly under appreciated/valued at this moment in time

Nice to see our 3 new products already hitting the media.

However I really wish they would move on now from the opening line of “the company who has seen its share price rise 1,500%’. Not the most encouraging thing to read as a new investor thinking it been over cooked.

Fali, you read my mind. Was just reviewing the charts.
7th April £2.14 Close
14th April £4.92 Close

History repeating. Fingers crossed